Most GLP-1 marketing targets 15–30 pound losses. But patients with 50+ pounds to lose stand to benefit most — and their experience is meaningfully different.
Most telehealth GLP-1 marketing is calibrated for the patient who wants to lose 15–30 pounds. The testimonials feature that range. The before-and-after imagery reflects it. The pricing tiers are structured around it.
But a substantial portion of GLP-1 patients — arguably the ones who stand to benefit most — are starting from a point where they need to lose 50, 75, or 100+ pounds. Their experience with these medications, and with the telehealth platforms that prescribe them, is meaningfully different.
The STEP trials — the landmark semaglutide studies — enrolled patients with BMIs of 30+ or 27+ with comorbidities. The average weight loss across these trials was approximately 15–17% of body weight over 68 weeks. For a patient starting at 300 pounds, that translates to roughly 45–50 pounds.
The SELECT trial demonstrated cardiovascular benefits with semaglutide, and the SURMOUNT trials showed tirzepatide producing even greater average weight loss — up to 22% of body weight. For patients with significant weight to lose, these numbers are not theoretical. They represent a medical intervention that can fundamentally alter health trajectories.
The telehealth experience is different for patients with significant weight to lose, in several specific ways:
For patients targeting significant weight loss, the most important provider characteristics are stability, clinical depth, and transparent long-term pricing. A platform that offers $149 for month one and $399 for month eight is not actually affordable for your situation.
Comprehensive weight loss and longevity platform with sustained clinical support.
Semaglutide from $179/mo · Tirzepatide from $209/mo
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
GLP-1 program with clinical monitoring for dose titration and long-term management.
From $297/mo · $399/mo at 7.5mg+
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Note: SHED pricing increases to $399/mo at doses of 7.5mg and above — factor this into long-term cost projections.
Multi-specialty telehealth including weight loss, with pharmacy-direct fulfillment.
From $199/mo
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
If you are starting GLP-1 therapy with 50+ pounds to lose, your intake consultation should cover more than "what's your goal weight?" A responsible provider will discuss:
GLP-1 medications are the most effective pharmacological tool ever developed for weight loss. For patients with significant weight to lose, they can be life-altering. But the medication alone is not a complete solution — and any telehealth platform that treats it as one is not serving patients with complex needs.
Look for providers who see the prescription as the beginning of a clinical relationship, not the end of a transaction.
Affiliate Disclosure: Virtual Health Visits earns commissions when readers sign up through certain links. This does not influence our coverage, rankings, or editorial independence. We review providers with and without affiliate programs equally.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication or treatment program.